leucine has been researched along with Cortical Lewy Body Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Arakawa, I; Nakamura, T; Oguri, T; Sakurai, K; Yuasa, H | 1 |
Bird, TD; Griffith, A; Leis, BC; Leverenz, JB; Mata, IF; Roberts, JW; Samii, A; Schellenberg, GD; Schneer, SH; Sidransky, E; Tsuang, D; Zabetian, CP | 1 |
2 other study(ies) available for leucine and Cortical Lewy Body Disease
Article | Year |
---|---|
[Anti-voltage-gated potassium channel (VGKC) complex/leucine-rich glioma-inactivated protein 1 (LGI1) antibody-associated limbic encephalitis mimicking dementia with Lewy bodies in a patient with subacute REM sleep behavior disorder].
Topics: Aged; Antibodies; Autoantibodies; Female; Glioma; Humans; Intracellular Signaling Peptides and Proteins; Leucine; Lewy Body Disease; Limbic Encephalitis; Potassium Channels, Voltage-Gated; REM Sleep Behavior Disorder; Sleep-Wake Transition Disorders | 2022 |
Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders.
Topics: Aged; Asparagine; Case-Control Studies; DNA Mutational Analysis; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Glucosylceramidase; Humans; Leucine; Lewy Body Disease; Male; Middle Aged; Mutation; Parkinson Disease; Proline; Risk Factors; Serine | 2008 |